Figure 3: Cumulative Incidence of Key Serologic Endpoints.
A: The cumulative percentage achieving HBsAg loss at week 240 was 5·3% in the TDF+PegIFN group and 4·1% in the TDF alone group (p=0·66).
B: The cumulative percentage achieving HBeAg loss at week 240 was 66·2% in the TDF+PegIFN group and 46·2% in the TDF alone group (p=0·009).